Category: Articles

Planning to Work in Retirement? Don’t Count on It

Daniel de Visé and USA TODAY on May 2, 2026

Nearly 3 in 4 workers plan to fund part of their retirement with a paycheck — but data going back to 1999 shows most never actually do.

European Wax Center Agrees to $5M Class Settlement. Do You Qualify?

Fernando Cervantes Jr. and USA TODAY on May 1, 2026

If you booked an appointment at WaxCenter.com between June 2023 and April 2026, you could be entitled to cash from a $5 million data privacy settlement.

Is Spirit Airlines Shutting Down Officially? What You Need to Know

Charles Curtis and For The Win on May 1, 2026

Spirit Airlines is reportedly preparing to shut down after failing to secure a $500 million federal bailout — and what happens to your tickets isn’t clear.

Your Relationship Status Is Now Linked to a Surprising Cancer Risk

Kristin Kurens on May 1, 2026

It’s not just your heart that marriage may be protecting.

Beat the Market: How to Reap the Cash-Back Rewards of Buying Gold at Costco

Kendall Blythe on May 1, 2026

Your favorite wholesaler even carries gold.

Ford Recalls Over 179K Vehicles. See Affected Models

Anthony Thompson and USA TODAY on May 1, 2026

A loose bolt in the front seat frame of 179,698 Ford Broncos and Rangers could prevent proper restraint in a crash — and owners won’t receive notification letters until May 11.

24 New Car Models That Will Cling to Their Resale Value

Kristin Kurens and Gillian Manning on May 1, 2026

A few auto manufacturers dominate this list from the experts at Kelley Blue Book.

Record-Low Consumer Sentiment Centers on Housing Crisis

Andrea Riquier and USA TODAY on May 1, 2026

A record 55% of Americans say their finances are getting worse, and housing — where property taxes are up 15% and insurance has jumped 70% — is the top culprit.

TrumpIRA Site Broadens Access to Retirement Plans. How to Enroll

Daniel de Visé and USA TODAY on May 1, 2026

Millions of workers without a workplace retirement plan will soon be able to open an IRA through a new government website — and may qualify for up to $1,000 in annual matching funds.

Money in a Minute for the Week Ending May 1, 2026

Stacy Johnson CPA on May 1, 2026

Here’s a quick roundup of the news that moved your money this week, from Money Talks News founder, Stacy Johnson.

Trump Says, “The Whole World, Unfortunately, Has Become Somewhat of a Casino” After U.S. Soldier Arrested for Winning Bet Using Classified Information

Kendall Blythe on May 1, 2026

Insider betting takes on a whole new meaning when you helped plan the mission you bet on.

Almost Half of New Retirees Got Pushed Out Early — 7 Ways to Be Ready

Stacy Johnson CPA on May 1, 2026

Most workers expect to retire at 65. The data says you probably won’t make it. Here’s what to do.

Exercising at This Time of Day May Lower Your Blood Pressure by Nearly Twice as Much

Kristin Kurens on May 1, 2026

Research says this matters almost as much as whether you work out at all, especially if you’re already at risk for heart disease.

Electric Pickup and Hybrid SUVs Power Kia’s Push for More U.S. Sales

Mark Phelan and Detroit Free Press on May 1, 2026

Kia is rolling out a hybrid Telluride and a sub-$40,000 EV SUV — plus its first-ever American-style pickup by 2030 to crack 1 million U.S. sales.

When Does Hurricane Season Start? Do These Things Before June 1

Doyle Rice and USA TODAY on May 1, 2026

Most people stock batteries before a hurricane — but a 30-day insurance deadline and 9 other less-obvious prep steps could be far more important.

US Prescription Spending Could Top $1 Trillion. GLP-1s Lead the Way

Ken Alltucker and USA TODAY on April 30, 2026

GLP-1 drugs powered a 13% prescription spending surge in 2025, and a new ASHP report says American drug costs could blow past $1 trillion this year.

FDA Proposes Curbs on Mass Copycats of Novo, Lilly’s Weight-Loss Drugs

Mariam Sunny, Reuters on April 30, 2026

The FDA’s proposal to remove semaglutide and tirzepatide from a key compounding list could raise prices for millions of Americans using cheaper GLP-1 alternatives.